标题
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
作者
关键词
-
出版物
Cancers
Volume 15, Issue 4, Pages 1171
出版商
MDPI AG
发表日期
2023-02-13
DOI
10.3390/cancers15041171
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is GRP78 (Glucose-regulated protein 78) a prognostic biomarker in differents types of cancer? A systematic review and meta-analysis
- (2023) Natália Souza dos Santos et al. PATHOLOGY RESEARCH AND PRACTICE
- CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens
- (2023) John Maher et al. Biology-Basel
- CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
- (2022) Nikhil Hebbar et al. Nature Communications
- HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease
- (2022) José Manuel Martín-Villa et al. Frontiers in Immunology
- Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
- (2022) Jong-Ho Cha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
- (2022) Hongjia Zhu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
- (2022) Stephen L. Chan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
- (2022) Changsong Qi et al. NATURE MEDICINE
- CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells
- (2022) Ali Bashiri Dezfouli et al. Frontiers in Immunology
- Targeting of the alphav beta3 integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma
- (2022) Dustin A Cobb et al. Journal for ImmunoTherapy of Cancer
- Role of GD3 Synthase ST8Sia I in Cancers
- (2022) Angelina Kasprowicz et al. Cancers
- ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
- (2022) Iacopo Petrini et al. Cancers
- The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease
- (2022) Mitsuharu Endo et al. Frontiers in Cell and Developmental Biology
- Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target
- (2022) Jiawei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results.
- (2022) Naval Guastad Daver et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim results of an ongoing phase 1/2a study of HPN328, a tri-specific, half-life extended, DLL3-targeting, T-cell engager, in patients with small cell lung cancer and other neuroendocrine cancers.
- (2022) Melissa Lynne Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- FGFR4-targeted chimeric antigen receptors (CARs) combined with anti-myeloid poly-pharmacy effectively treats orthotopic rhabdomyosarcoma
- (2022) Peter M. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- Anti-extra domain B splice variant of fibronectin antibody drug conjugate eliminates tumors with enhanced efficacy when combined with checkpoint blockade
- (2022) Andrea T. Hooper et al. MOLECULAR CANCER THERAPEUTICS
- Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K–specific inhibition
- (2022) Eric T. Baldwin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
- (2022) Wei Yu et al. Frontiers in Cell and Developmental Biology
- CD24: A Novel Target for Cancer Immunotherapy
- (2022) Emmanouil Panagiotou et al. Journal of Personalized Medicine
- Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS
- (2022) Fengping Li et al. JOURNAL OF PROTEOME RESEARCH
- DLK1 ‐directed chimeric antigen receptor T‐cell therapy for hepatocellular carcinoma
- (2022) Yangyang Zhai et al. LIVER INTERNATIONAL
- DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
- (2022) James Yao et al. ONCOLOGIST
- Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
- (2022) Bihui Cao et al. Nature Communications
- Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues
- (2022) Aidan Burn et al. PLOS BIOLOGY
- Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
- (2022) Yixin Jin et al. Molecular Therapy-Oncolytics
- Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
- (2022) Celia Martín-Otal et al. Journal for ImmunoTherapy of Cancer
- CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
- (2022) Zhijie Zhang et al. Cells
- Sacituzumab govitecan and other antibody-drug conjugates targeting trophoblast cell-surface antigen 2 (Trop-2) in breast cancer
- (2022) Ashley Matusz-Fisher et al. Annals of Translational Medicine
- CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations
- (2022) Ling Tang et al. Clinical and Translational Medicine
- Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
- (2022) Niklas Klümper et al. CLINICAL CANCER RESEARCH
- Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells
- (2022) Emma Halliwell et al. CYTOTHERAPY
- The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy
- (2022) Inbar Arman et al. Cells
- CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumors
- (2021) Huanpeng Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive T Cell Immunotherapy for Medullary Thyroid Carcinoma Targeting GDNF Family Receptor alpha 4
- (2021) Vijay G. Bhoj et al. Molecular Therapy-Oncolytics
- Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
- (2021) Runzhe Shu et al. Molecular Therapy-Oncolytics
- P2X7 Variants in Oncogenesis
- (2021) Anna Pegoraro et al. Cells
- Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 TAHOE Study
- (2021) Fiona Blackhall et al. Journal of Thoracic Oncology
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
- (2021) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of non-viral ligand-dependent EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
- (2021) Hiroshi Kubo et al. Molecular Therapy-Oncolytics
- Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
- (2021) Nattaporn Phanthaphol et al. Frontiers in Oncology
- CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells
- (2021) Corinna Haist et al. ORAL ONCOLOGY
- First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
- (2021) François Anna et al. Journal for ImmunoTherapy of Cancer
- Ancient Adversary – HERV-K (HML-2) in Cancer
- (2021) Eoin Dervan et al. Frontiers in Oncology
- First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
- (2021) Michael L. Maitland et al. CLINICAL CANCER RESEARCH
- A phase 1 study of TAK-164, an anti-guanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) cancers expressing GCC.
- (2021) Richard D. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results from a phase 1 study of AMG 757, a half-life extended bispecific T-cell engager (BiTE) immuno-oncology therapy against delta-like ligand 3 (DLL3), in small cell lung cancer (SCLC).
- (2021) Taofeek K. Owonikoko et al. JOURNAL OF CLINICAL ONCOLOGY
- TROPION-PanTumor01: Dose analysis of the TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd, DS-1062) for the treatment (Tx) of advanced or metastatic non-small cell lung cancer (NSCLC).
- (2021) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of soluble EphB4-albumin in combination with PD-1 antibody (pembrolizumab) in relapsed/refractory head neck squamous cell carcinoma.
- (2021) Alexandra Jackovich et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
- (2021) Michael S. Hwang et al. Nature Communications
- Third-Generation Anti-CD47-Specific CAR-T Cells Effectively Kill Cancer Cells and Reduce the Genes Expression in Lung Cancer Cell Metastasis
- (2021) Huyen Thi La et al. Journal of Immunology Research
- A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
- (2021) Patrick Schöffski et al. Oncology Research and Treatment
- PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
- (2021) Yamin Jie et al. Frontiers in Immunology
- CAR T-cell therapy for multiple myeloma: state of the art and prospects
- (2021) Niels W C J van de Donk et al. Lancet Haematology
- Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
- (2021) Giulia Pellizzari et al. Journal for ImmunoTherapy of Cancer
- Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
- (2021) Hiroko Ishii et al. Cancers
- First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose
- (2021) Qingtang Lin et al. Frontiers in Oncology
- The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer
- (2021) Xixun Zhang Frontiers in Oncology
- CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
- (2021) Yinjiang Zhang et al. Frontiers in Cell and Developmental Biology
- Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancer
- (2021) F. Schettini et al. ESMO Open
- GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
- (2021) Sabine Heitzeneder et al. CANCER CELL
- The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer
- (2021) James F H Pittaway et al. ENDOCRINE-RELATED CANCER
- Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
- (2021) Subhajit Chatterjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer
- (2021) Hanning Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
- (2021) Sakiko Harada et al. MOLECULAR THERAPY
- Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
- (2021) Xiao-Hong Chen et al. Translational Oncology
- 480 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6
- (2021) Gerald Falchook et al. Journal for ImmunoTherapy of Cancer
- Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice
- (2021) Ancy Thomas et al. JCI Insight
- Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
- (2020) Dongrui Wang et al. Science Translational Medicine
- Chimeric antigen receptor‐modified T‐cell therapy for platelet‐derived growth factor receptor α‐positive rhabdomyosarcoma
- (2020) Wei Xiao et al. CANCER
- Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas
- (2020) William D. Tap et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Human fibronectin Extra Domain B (ED‐B) as a biomarker for targeted therapy in cancer
- (2020) Relinde I.Y. Lieverse et al. Molecular Oncology
- Cancer cell therapies: the clinical trial landscape
- (2020) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Using apelin-based synthetic Notch receptors to detect angiogenesis and treat solid tumors
- (2020) Zhifu Wang et al. Nature Communications
- GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab
- (2020) Daiki Kato et al. eLife
- NKp30 – a prospective target for new cancer immunotherapy strategies
- (2020) Pedro F. Pinheiro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics
- (2020) Max London et al. MOLECULAR BIOLOGY REPORTS
- P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
- (2020) Romain Lara et al. Frontiers in Pharmacology
- An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
- (2020) Joseph Robinson et al. Journal of Pathology Clinical Research
- CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
- (2020) Valeria Leuci et al. CLINICAL CANCER RESEARCH
- Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
- (2020) Hsiang-chi Tseng et al. Nature Communications
- CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
- (2020) Xiaodong Zhuang et al. JCI Insight
- Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer
- (2020) Fangmei Fu et al. Frontiers in Molecular Biosciences
- An engineered 4-1BBL fusion protein with “activity on demand”
- (2020) Jacqueline Mock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectin
- (2020) Jessica Wagner et al. Cancer Immunology Research
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase 1a/1b study of first-in-class B7-H4 antibody, FPA150, as monotherapy in patients with advanced solid tumors.
- (2019) Jasgit C. Sachdev et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
- (2019) Kayla V. Myers et al. Molecular Cancer
- CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
- (2019) Lynsey M. Whilding et al. Cancers
- Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy
- (2019) Liangliang Xu et al. Stem Cell Research & Therapy
- The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
- (2019) Sen Wang et al. Frontiers in Oncology
- TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
- (2019) Alisha Holtzhausen et al. Cancer Immunology Research
- CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities–Merits and Challenges
- (2019) Dennis C. Harrer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
- (2019) Michael Ruff et al. NEURO-ONCOLOGY
- CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo
- (2019) Xiaojun Tang et al. OncoTargets and Therapy
- CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
- (2019) Sara Cano-Crespo et al. Scientific Reports
- CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
- (2019) Alexandra Landras et al. Cancers
- Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
- (2019) Ren-Yu Zhang et al. Frontiers in Cell and Developmental Biology
- CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies
- (2019) Alba Rodriguez-Garcia et al. MOLECULAR THERAPY
- A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
- (2018) Jing Wei et al. CELLULAR IMMUNOLOGY
- Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
- (2018) Erhao Zhang et al. Journal of Hematology & Oncology
- Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer
- (2018) Gemma L. Owens et al. JOURNAL OF IMMUNOTHERAPY
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Engineering Axl specific CAR and SynNotch receptor for cancer therapy
- (2018) Jang Hwan Cho et al. Scientific Reports
- Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
- (2018) Michael S. Magee et al. Cancer Immunology Research
- Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
- (2018) Kevin K. Chang et al. Oncogenesis
- Abstract CT056: The first-in-human clinical trial of MG7-CART for metastasis colon cancer
- (2018) Jijun Yuan CANCER RESEARCH
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors
- (2017) Geoffrey I. Shapiro et al. INVESTIGATIONAL NEW DRUGS
- Therapy of Advanced Non–Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
- (2017) Rebecca Suk Heist et al. JOURNAL OF CLINICAL ONCOLOGY
- Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
- (2017) Haiyong Peng et al. JOURNAL OF MOLECULAR BIOLOGY
- Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
- (2017) Lynsey M. Whilding et al. MOLECULAR THERAPY
- Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
- (2017) Alec J. Walker et al. MOLECULAR THERAPY
- CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
- (2017) Vita Golubovskaya et al. Cancers
- A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
- (2017) Stina Wichert et al. PLoS One
- Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
- (2017) Spencer Park et al. Scientific Reports
- Fibronectin-targeted drug delivery in cancer
- (2016) Heena Kumra et al. ADVANCED DRUG DELIVERY REVIEWS
- Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target
- (2016) Alfredo Perales-Puchalt et al. CLINICAL CANCER RESEARCH
- CD317 Promotes the survival of cancer cells through apoptosis-inducing factor
- (2016) Xin Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
- (2016) Ronan T. Swords et al. LEUKEMIA RESEARCH
- Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy
- (2016) Jenessa B Smith et al. MOLECULAR THERAPY
- GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
- (2016) Michael S. Magee et al. OncoImmunology
- Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma
- (2015) J. Krishnamurthy et al. CLINICAL CANCER RESEARCH
- GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
- (2015) L. Rasche et al. HAEMATOLOGICA
- GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
- (2015) L. Rasche et al. HAEMATOLOGICA
- Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer
- (2015) K. Urbanska et al. Cancer Immunology Research
- Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras
- (2015) Fuling Zhou et al. OncoImmunology
- Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
- (2014) Rachel E Beard et al. Journal for ImmunoTherapy of Cancer
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
- (2013) C. Geldres et al. CLINICAL CANCER RESEARCH
- Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
- (2013) David S. Ritchie et al. MOLECULAR THERAPY
- Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice
- (2012) Amit Maliar et al. GASTROENTEROLOGY
- An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo
- (2012) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
- (2012) Guilly Rebagay et al. Frontiers in Oncology
- Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models
- (2011) Eric S. White et al. IUBMB LIFE
- Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors
- (2010) A. S. Y. Lo et al. CLINICAL CANCER RESEARCH
- Targeting the embryonic gene Cripto-1 in cancer and beyond
- (2010) Caterina Bianco et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search